
Heliyon, Journal Year: 2024, Volume and Issue: 10(19), P. e38369 - e38369
Published: Sept. 24, 2024
Language: Английский
Heliyon, Journal Year: 2024, Volume and Issue: 10(19), P. e38369 - e38369
Published: Sept. 24, 2024
Language: Английский
Journal of Pharmaceutical and Biomedical Analysis, Journal Year: 2024, Volume and Issue: 243, P. 116117 - 116117
Published: March 19, 2024
Language: Английский
Citations
4Rapid Communications in Mass Spectrometry, Journal Year: 2024, Volume and Issue: 39(5)
Published: Dec. 10, 2024
The present study aims to establish structures of the degradation products an anti-diabetic drug, Imeglimin (IMG) approved for treatment type 2 diabetes mellitus in year 2021. Degradation pathways are proposed along with silico toxicity assessments observed (DPs) drug.
Language: Английский
Citations
1Journal of Chromatography B, Journal Year: 2024, Volume and Issue: 1247, P. 124319 - 124319
Published: Sept. 13, 2024
Language: Английский
Citations
0Heliyon, Journal Year: 2024, Volume and Issue: 10(19), P. e38369 - e38369
Published: Sept. 24, 2024
Language: Английский
Citations
0